Seeking Alpha

Salix Pharmaceuticals (SLXP +0.2%) says it's submitted a New Drug Application to the FDA for its...

Salix Pharmaceuticals (SLXP +0.2%) says it's submitted a New Drug Application to the FDA for its HIV-induced diarrhea drug Crofelemer. The agency has 60 days to review the application and decide whether it will enter its review process. The drug developer is also researching alternative possible uses for the drug, including the treatment of irritable bowel syndrome.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector